These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 9931394

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effects of intraportal prostaglandin E1 administration on hepatic warm ischemia and reperfusion injury in dogs.
    Totsuka E, Sasaki M, Takahashi K, Toyoki Y, Seino K, Chiba S, Narumi S, Hakamada K, Morita T, Konn M.
    Surg Today; 1995; 25(5):421-8. PubMed ID: 7640470
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of intraportal prostaglandin E1 on adhesion molecule expression, inflammatory modulator function, and histology in canine hepatic ischemia/reperfusion injury.
    Hafez T, Moussa M, Nesim I, Baligh N, Davidson B, Abdul-Hadi A.
    J Surg Res; 2007 Mar; 138(1):88-99. PubMed ID: 17174338
    [Abstract] [Full Text] [Related]

  • 6. The effect of intraportal administration of prostaglandin E1 on liver blood flow and liver function.
    Inagaki H, Kurokawa T, Nonami T, Miwa T, Nakao A, Takagi H.
    Hepatogastroenterology; 1999 Mar; 46(29):2909-13. PubMed ID: 10576371
    [Abstract] [Full Text] [Related]

  • 7. The effect of intraportal PGE1 on warm ischemic liver damage.
    Totsuka E, Sasaki M, Takahashi K, Toyoki Y, Seino K, Hakamada K, Konn M.
    Surg Today; 1994 Mar; 24(11):1028-30. PubMed ID: 7772903
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Continuous infusion of prostaglandin E1 via the superior mesenteric artery can prevent hepatic injury in hepatic artery interruption through passive portal oxygenation.
    Sato T, Kato T, Kurokawa T, Yasui O, Hiroshi N, Miyazawa H, Asanuma Y, Koyama K.
    Liver; 2000 Apr; 20(2):179-83. PubMed ID: 10847488
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of continuous infusion of prostaglandin E1 through the superior mesenteric artery against ischemic liver cell necrosis after hepatic artery occlusion.
    Kato T, Sato T, Kurokawa T, Nanjo H, Asanuma Y, Koyama K.
    Transplantation; 2003 Nov 15; 76(9):1340-5. PubMed ID: 14627913
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of prostaglandin E1 infused via the superior mesenteric artery on partially resected, dearterialized canine liver.
    Huang HM, Tanaka H, Jin SW, Tanaka S, Yamamoto T, Kubo S, Hirohashi K, Kinoshita H.
    Osaka City Med J; 2003 Jun 15; 49(1):11-9. PubMed ID: 14703095
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.